HAE: Haemonetics Corporation Stock

by  •  • Comments Off on HAE: Haemonetics Corporation Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 3,110.70
Enterprise Value ($M) 4,014.69
Book Value ($M) 906.86
Book Value / Share 18.05
Price / Book 3.43
NCAV ($M) -618.54
NCAV / Share -12.31
Price / NCAV -5.03

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.14

Liquidity (mrq)
Quick Ratio 2.55
Current Ratio 3.97

Balance Sheet (mrq) ($M)
Current Assets 1,005.87
Assets 2,531.27
Liabilities 1,624.41
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-04 13G/A Capital Research Global Investors 3.10 -64.50
11-14 13G T. Rowe Price Investment Management, Inc. 5.60
11-08 13G/A Wellington Management Group Llp 8.27 29.46

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 28, 2024 ☐ TRANSITION REPORT PURSUANT
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 28, 2024 ☐ TRANSITION REPORT PURSUAN
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 29, 2024 ☐ TRANSITION REPORT PURSUANT TO
2024-05-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-25 47,216 216,461 21.81
2025-04-24 68,061 319,992 21.27
2025-04-23 62,701 315,451 19.88
2025-04-22 66,530 410,643 16.20

(click for more detail)

Similar Companies
EW – Edwards Lifesciences Corporation GKOS – Glaukos Corporation
GMED – Globus Medical, Inc. INSP – Inspire Medical Systems, Inc.
ITGR – Integer Holdings Corporation


Financial data and stock pages provided by
Fintel.io